Wednesday, 2 January 2019

Large-Scale Commercial Production Approved for Factor Xa Inhibition Reversal Agent - Pharmacy Times

Large-Scale Commercial Production Approved for Factor Xa Inhibition Reversal Agent  Pharmacy Times

Officials with the FDA approved Portola Pharmaceuticals' Prior Approval Supplement (PAS) for the Generation 2 manufacturing process for Andexxa ...

No comments:

Post a Comment